Vera Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Vera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $81.3, which forecasts a 100.59% increase in the stock price over the next year. The lowest target is $33 and the highest is $110.

Price Target: $81.3 (+100.59%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$33	$81.3	$95	$110
Change	-18.58%	+100.59%	+134.39%	+171.40%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	3	3	5	5	5	4
Buy	4	4	4	4	4	5
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	11	11	11	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andy Chen Wolfe Research	Wolfe Research	Hold → Buy Upgrades $88	Hold → Buy	Upgrades	$88	+117.12%	Mar 11, 2026
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $90 → $110	Strong Buy	Maintains	$90 → $110	+171.40%	Mar 2, 2026
Dina Ramadane B of A Securities	B of A Securities	Strong Buy Maintains $48 → $66	Strong Buy	Maintains	$48 → $66	+62.84%	Dec 19, 2025
Paul Choi Goldman Sachs	Goldman Sachs	Strong Buy Maintains $55 → $95	Strong Buy	Maintains	$55 → $95	+134.39%	Dec 19, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $99 → $96	Buy	Maintains	$99 → $96	+136.86%	Dec 19, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

45.42M

Revenue Next Year

247.69M

from 45.42M

445.28%

from 45.42M

EPS This Year

-4.76

from -4.66

EPS Next Year

-3.29

from -4.76

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	45.42M	247.69M
Revenue Growth	-	-	-	-	-	-	445.28%
EPS	-2.43	-3.35	-2.25	-2.75	-4.66	-4.76	-3.29
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	128.8M	495.4M
Avg	45.4M	247.7M
Low	12.7M	135.6M

Revenue Growth

Revenue Growth	2026	2027
High	-	990.6%
Avg	-	445.3%
Low	-	198.5%

EPS Forecast

EPS	2026	2027
High	-3.34	0.88
Avg	-4.76	-3.29
Low	-5.93	-5.11

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.